WBC
TAK icon

West Branch Capital’s Takeda Pharmaceutical TAK Stock Holding History

West Branch Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed -$47 – 612
2024
Q3 		$47 Buy
+3
New +$43 ﹤0.01% 583
2023
Q4 		– Sell
-93
Closed -$1.44K – 467
2023
Q3 		$1.44K Hold
93
– – ﹤0.01% 394
2023
Q2 		$1.46K Hold
93
– – ﹤0.01% 398
2023
Q1 		$1.53K Hold
93
– – ﹤0.01% 400
2022
Q4 		$1.45K Hold
93
– – ﹤0.01% 397
2022
Q3 		$1K Buy
+93
New +$1.29K ﹤0.01% 431

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

West Branch Capital's TAK Position: Q4 2024 in Review

West Branch Capital sold out of Takeda Pharmaceutical (TAK) in Q4 2024, closing a stake of 3 shares — an estimated $47 sold.

West Branch Capital first reported a position in TAK in Q3 2022 and held it in 6 quarters. The position peaked at $1.53K in Q1 2023. 299 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

  • West Branch Capital reported no remaining Takeda Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • West Branch Capital sold 3 Takeda Pharmaceutical shares in Q4 2024, an estimated $47.
  • West Branch Capital first reported a position in Takeda Pharmaceutical in Q3 2022 and held it in 6 quarters.
  • West Branch Capital's Takeda Pharmaceutical position peaked at $1.53K in Q1 2023.
  • 299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on West Branch Capital's 13F filing for Q4 2024, filed 17 Jan 2025.